Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT03924466
What this trial is testing

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Who this might be right for
Metastatic Breast CarcinomaLocally Advanced Breast CancerCancer of Pancreas+11 more
Universitair Ziekenhuis Brussel 55
Not applicableLooking for participantsNCT07235007
What this trial is testing

Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma

Who this might be right for
Extrahepatic Cholangiocarcinoma
Aichi Medical University 120
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269158
What this trial is testing

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsAdvanced CancerImmunotherapy
Yonsei University 160
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194
What this trial is testing

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Who this might be right for
Locally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more
National Cancer Institute (NCI) 103
Not applicableStudy completedNCT02685631
What this trial is testing

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Who this might be right for
Localized Non-Resectable Adult Liver Carcinoma
Vanderbilt-Ingram Cancer Center 1,653
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Looking for participantsNCT07025174
What this trial is testing

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Bile Duct CarcinomaGall Bladder CancerBiliary Tract Cancer+1 more
First Affiliated Hospital of Zhejiang University 60
Testing effectiveness (Phase 2)Ended earlyNCT01383746
What this trial is testing

Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION

Who this might be right for
Cholestasis, Progressive Familial Intrahepatic 3
Assistance Publique - Hôpitaux de Paris 5
Early research (Phase 1)Study completedNCT01242605
What this trial is testing

ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaGallbladder Neoplasms
University College, London 13
Not applicableUnknownNCT05662488
What this trial is testing

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Who this might be right for
Hepatocellular CarcinomaBile Duct Cancer
Peking Union Medical College Hospital 25
Not applicableUnknownNCT04415190
What this trial is testing

The Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

Who this might be right for
Cholangiocarcinoma
Central Hospital, Nancy, France 150
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Large-scale testing (Phase 3)Looking for participantsNCT06355427
What this trial is testing

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Mara Veenstra, MD 81
Large-scale testing (Phase 3)UnknownNCT02232490
What this trial is testing

Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L

Who this might be right for
Hepatocellular CarcinomaHCCLiver Cancer
Immunitor LLC 120
Testing effectiveness (Phase 2)Looking for participantsNCT07063888
What this trial is testing

A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow Margin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801083
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula 4
Early research (Phase 1)Study completedNCT01438554
What this trial is testing

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Who this might be right for
Solid TumorsThyroid CancerSoft-tissue Sarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 89
Next Page